PRKN and Parkinson disease: The prevailing hypothesis for PD associated with PRKN mutations (also known as PARK2) is that a decrease in Parkin activity alters the mitophagy machinery and results in increased α-synuclein aggregation and accumulation in the lysosomes (Wang et al., 2022).